Director, Health Economics
- Designing and executing interventional and observational research studies consistent with overall payer strategies.
- Building and refining pharmacoeconomic models (e.g. budget impact models).
Direct Customer Interactions:
- Lead the Medical team in the development of interaction plans concerning managed care customers;
- Communicate approved outcomes data proactively, and accurately respond to customer questions during scientific exchanges;
- Develop Health Technology Assessments that include AMCP Dossiers;
- Successfully interact with formulary decision makers, their influencers, healthcare policy makers, and health economists in both one-on-one and group settings in accordance with Company policies, applicable laws and regulations, and ethical standards; and
- Fully understand and gain insight into (1) formulary and reimbursement policies, (2) the outcomes research activities taking place within the Disease Area, (3) the needs and interests of healthcare payer organizations, (4) the thinking and recommendations being formulated by policy makers involved in cost effectiveness and healthcare value issues, and (5) the clinical and consumer healthcare needs of patients.
- PhD, PharmD, MS, MPH degree with 7 years’ experience working in outcomes research, health economics and/or epidemiologic issues in the pharmaceutical industry;
- Must be knowledgeable about all available data and possess the ability to effectively interpret and communicate the data;
- Must demonstrate strong strategic leadership and neurology/psychiatry expertise;
- Ability to understand and interpret the US market in order to make successful HOER recommendations;
- Demonstrated ability in problem solving and communications skills;
- Previous experience overseeing projects with the ability to work autonomously with minimal supervision;
- Relevant scientific experience in clinical setting or within pharmaceutical industry;
- Previous experience in participating in research and publication efforts;
- Strong understanding of healthcare economics, epidemiology, clinical research, Commercial payer, Government payer, and Managed Care and formulary issues; and
- Ability to travel up to 20% of time.